224 related articles for article (PubMed ID: 22723956)
1. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.
Du L; Subauste MC; DeSevo C; Zhao Z; Baker M; Borkowski R; Schageman JJ; Greer R; Yang CR; Suraokar M; Wistuba II; Gazdar AF; Minna JD; Pertsemlidis A
PLoS One; 2012; 7(6):e39167. PubMed ID: 22723956
[TBL] [Abstract][Full Text] [Related]
2. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A.
Lu J; Zhou L; Wu B; Duan Y; Sun Y; Gu L; Xu D; Du C
Exp Cell Res; 2020 Feb; 387(1):111752. PubMed ID: 31805277
[TBL] [Abstract][Full Text] [Related]
3. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
[TBL] [Abstract][Full Text] [Related]
4. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
Tan MH; De S; Bebek G; Orloff MS; Wesolowski R; Downs-Kelly E; Budd GT; Stark GR; Eng C
Breast Cancer Res Treat; 2012 Feb; 131(3):849-58. PubMed ID: 21479552
[TBL] [Abstract][Full Text] [Related]
5. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
Xu X; Jin S; Ma Y; Fan Z; Yan Z; Li W; Song Q; You W; Lyu Z; Song Y; Shi P; Liu Y; Han X; Li L; Li Y; Liu Y; Ye Q
J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
[TBL] [Abstract][Full Text] [Related]
6. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
Cao XM
Cancer Biomark; 2019; 24(3):257-267. PubMed ID: 30883336
[TBL] [Abstract][Full Text] [Related]
7. DNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line.
Che CL; Zhang YM; Zhang HH; Sang YL; Lu B; Dong FS; Zhang LJ; Lv FZ
Int J Clin Exp Pathol; 2013; 6(8):1538-48. PubMed ID: 23923072
[TBL] [Abstract][Full Text] [Related]
8. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.
Chatterjee A; Chattopadhyay D; Chakrabarti G
PLoS One; 2014; 9(4):e95716. PubMed ID: 24755562
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.
Zhou J; Hu Q; Zhang X; Zheng J; Xie B; Xu Z; Zhang W
Oncol Rep; 2018 Apr; 39(4):1783-1792. PubMed ID: 29393480
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
[TBL] [Abstract][Full Text] [Related]
11. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
[TBL] [Abstract][Full Text] [Related]
12. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
Li S; Mei Z; Hu HB; Zhang X
J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
[TBL] [Abstract][Full Text] [Related]
14. SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers.
Matsuura S; Kahyo T; Shinmura K; Iwaizumi M; Yamada H; Funai K; Kobayashi J; Tanahashi M; Niwa H; Ogawa H; Takahashi T; Inui N; Suda T; Chida K; Watanabe Y; Sugimura H
Sci Rep; 2013 Oct; 3():3012. PubMed ID: 24146025
[TBL] [Abstract][Full Text] [Related]
15. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
Qi MM; Ge F; Chen XJ; Tang C; Ma J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
[TBL] [Abstract][Full Text] [Related]
16. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
[TBL] [Abstract][Full Text] [Related]
18. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
[TBL] [Abstract][Full Text] [Related]
19. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
20. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
Niu N; Schaid DJ; Abo RP; Kalari K; Fridley BL; Feng Q; Jenkins G; Batzler A; Brisbin AG; Cunningham JM; Li L; Sun Z; Yang P; Wang L
BMC Cancer; 2012 Sep; 12():422. PubMed ID: 23006423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
